Results 51 to 60 of about 10,833,780 (300)

Antea Group Archeologie 2020/72

, 2020
Auteurs: R. Fens & I. Fleuren rapportvolgnummer: 2020/72 Antea Group projectnummer 271507 ARCHIS-nr 4856764100 Het plangebied ligt langs de voormalige Zuiderzeekust. De vestingstad Muiden, een van oorsprong middeleeuwse stad, bevindt zich aan de monding
Koopmanschap, H (Antea Group), Fens, R. (Antea Group), Jong, M. de (Antea Group), Kauling, T.A. (Antea Group), Van der Veen, V. (Antea Group), Thasing, S (Antea Group), Brokke, A. (Antea Group), Fleuren, I (Antea Group), Fleuren, I. (Antea Group), Fleuren, I (Antea Group), ProjectMember, Fens, R.L. (Antea Group), ProjectMember, Sibma, T (Antea Group), Fens, R., Brokke, A.J. (Antea Group), Uffink, V. (Antea Group), Fens, R.L. (Antea Group), Fens, R (Antea Group)   +16 more
core   +1 more source

Cold Agglutinin Disease Unfurled in Laboratory and Blood Bank: A Little Poignant Observation Can Speak a Lot!

Archives of Medicine and Health Sciences
Autoimmune hemolytic anemias (AIHAs) are hemolytic anemias characterized by the production of autoantibodies against surface antigens on red blood cells.
Archana Shetty, Gurudatta Murthy, Bharadwaj Golithadka   +2 more
doaj   +1 more source

Antea Group Archeologie 2018/188

, 2021
In november 2018 heeft Antea Group een archeologisch bureauonderzoek uitgevoerd ten behoeve van de aanleg van een warmteleiding in Leeuwarden-Zuid, gemeente Leeuwarden. Na afloop van dit onderzoek hebben twee tracéwijzigingen plaatsgevonden. Na de eerste
Fens, R. (Antea Group), Fleuren, I. (Antea Group)   +1 more
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

SUCCESSFUL ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION FROM LIVING-RELATED DONOR IN HIGH-SENSITIZED PATIENT

Вестник трансплантологии и искусственных органов, 2012
This case report describes a patient initially found to have an extremely high anti-B IgM (1:1024) and IgG (1:512) titres.Additionally, patient had previous diseased donor kidney transplantation and high level of anti-HLA panel- reactive antibodies (60%).
A. I. Sushkov, N. V. Borovkova, N. V. Doronina   +2 more
doaj   +1 more source

Programmes for the management of preoperative anaemia: audit in ten European hospitals within the PaBloE (Patient Blood Management in Europe) Working Group [PDF]

, 2019
Background and objectives: Preoperative anaemia is an independent risk factor for a higher morbidity and mortality, a longer hospitalization and increased perioperative transfusion rates.
Humbrecht, Catherine, Seifried, Erhard, Markus M. Müller, Meybohm, P., Laspina, S., Rigal, Jean-Christophe, Catherine Humbrecht, Stefan Laspina, Pendry, K., Wikman, Agneta, Sigismond Lasocki, Geisen, Christof, Muhling, J., Christof Geisen, Jean‐Christophe Rigal, Gilles Folléa, Jung‐König, Mona, Paola Manzini, Agneta Wikman, Geisen, C., Mona Jung‐König, Christoph Füllenbach, Kai Zacharowski, Kari Aranko, Jörg Mühling, Murphy, Michael F., Rigal, Jean‐Christophe, Müller, Markus M., Manzini, Paola, Humbrecht, C., Lasocki, S., Kate Pendry, Erhard Seifried, Lasocki, Sigismond, Murphy, M.F., Wikman, A., Laspina, Stefan, Zacharowski, Kai, Aranko, Kari, Füllenbach, C., Folléa, G., Mühling, Jörg, Folléa, Gilles, Meybohm, Patrick, Manzini, P., Jung-Konig, Mona, Jung-König, M., Rigal, J.C., Patrick Meybohm, Füllenbach, Christoph, Müller, M.M., Michael F. Murphy, PBloE (Patient Blood Management in Europe) Working Group, Zacharowski, K., Pendry, Kate, Seifried, E., Aranko, K.   +56 more
core   +2 more sources

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

FEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

Variable manifestations of minor blood group incompatibility

International Journal of Contemporary Pediatrics, 2022
In settings with adequate coverage of anti-D immunoglobulin, minor blood group incompatibility has become an important cause of hemolytic disease of the newborn (HDN). We presented a series of cases of HDN of varying severities caused due to presence of anti-E and anti-C antibodies.
Pankaj Chaudhary, Risha Devi, Gugloth Krishna Charan, Zikra Syed, Daljit Kaur, Mayank Priyadarshi   +5 more
openaire   +1 more source

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

Aging and Cancer, EarlyView.
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi, Emily Herdman, Danielle Westmark, Vijaya R. Bhatt   +3 more
wiley   +1 more source

Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients [PDF]

Vojnosanitetski Pregled, 2009
Background/Aim. Due to improved methods for removal of ABO isoagglutinins and novel immunosuppressive protocols, short and long term outcome in blood group incompatible is similar to blood group compatible kidney transplantation.
Ignjatović Ljiljana, Kovačević Zoran, Jovanović Dragan, Vavić Neven, Paunić Zoran, Radojević Milorad, Rabrenović Violeta, Obrenčević Katarina, Mijušković Mirjana, Draškovic-Pavlović Biljana, Ostojić Gordana, Balint Bela, Bokonjić Dubravko   +12 more
doaj   +1 more source